Towa Pharmaceutical Co., Ltd. · TSE:4553
Towa Pharmaceutical — FY2008 Earnings Presentation
25 slides from Towa Pharmaceutical's earnings presentation, May 16, 2008
Slide 1: Fiscal 2008 results briefing (4553)
2008 3 2008 5 16 ( 4553)
Slide 2: CONTENTS
CONTENTS . 2008 3 2 . 2009 3 12 -1-
Slide 3: FY2008 (March 2008) results
. 2008 3
Slide 4: FY2008 results summary
2008 3 ( %) 08/3 07/3 31,495 +7.7 29,235 14,976 47.6 +9.7 13,646 46.7 9,690 30.8 +5.0 9,229 31.6 5,285 16.8 +19.7 4,416 15.1 5,146 16.3 +5.3 4,886 16.7 2,692 8.5 +3.6 2,598 8.9 -3-
Slide 5: Net sales change analysis
173 07 173 06 +525 +222 05 +362 +2,433 +434 +505 04 31,495 03 +385 02 29,235 07/3 08/3 -4-
Slide 6: D CR
315 320 5 07/7 07 (22 ) 292 9 06 (19 ) 7 27 06/7 23 270 20 242 16 02~05 05/7 10 34 29 05 (35 ) D 10 220 04/7 04 (18 ) CR 19 03 (14 ) 38 42 32 03/7 02 (23 ) 170 179 02/7 171 178 120 06/3 07/3 08/3 -5-
Slide 7: 06/3 07/3 08/3 CR -6-
25 06/3 07/3 20 08/3 15 10 5 0 CR -6-
Slide 8: ( ) 5.4% 25.9% 68.7% 08/3 5.4% 26.5% 68.1% 07/3 4.6% 26.9% 8.4% 06/3
( ) 5.4% 25.9% 68.7% 08/3 5.4% 26.5% 68.1% 07/3 4.6% 26.9% 68.4% 06/3 0 100 200 300 -7-
Slide 9: ( ) 3.0% 60.9% 26.0% 10.1% 3.1% 61.8% 24.8% 10.3% 3.0% 06 63.0% 23.7%
( ) 3.0% 07 60.9% 26.0% 10.1% 3.1% 07 61.8% 24.8% 10.3% 3.0% 06 63.0% 23.7% 10.2% 3.8% 06 61.8% 23.6% 10.8% 3.5% 05 64.0% 21.2% 11.2% 3.8% 05 65.1% 19.7% 11.4% -8-
Slide 10: z BE z TVCM
( ) 08/3 z 4,897 351 (4,546) 1,693 238 z BE (1,931) 793 145 (647) 2,306 202 z TVCM (2,104) 9,690 460 (9,229) -9-
Slide 11: ( ) 08/3 07/3 117.05 /$ 5,146 4,886 08 3 99.19 /$ 48 12
( ) 08/3 07/3 351 564 0 206 418 490 94 418 0 07 3 117.05 /$ 5,146 4,886 08 3 99.19 /$ 48 12 619 535 402 87 177 392 2,692 2,598 -10-
Slide 12: ( ) 08/3 07/3 1,179 ▲422 12,342 11,801 +540 1,414 +1,097 9,366 8,215 +1,150
( ) 08/3 07/3 757 1,179 ▲422 12,342 11,801 +540 1,414 316 +1,097 9,366 8,215 +1,150 225 644 ▲418 1,072 1,221 ▲149 25,177 23,378 +1,798 19,889 20,289 ▲400 45,066 43,668 +1,397 4,479 4,066 +412 4,559 5,211 ▲652 9,038 9,277 ▲239 1,090 1,120 ▲30 10,128 10,397 ▲269 34,938 33,270 +1,667 45,066 43,668 +1,3
Slide 13: FY2009 (March 2009) forecast
. 2009 3
Slide 14: FY2009 full-year forecast
2009 3 ( %) 09/3 ( ) 08/3 35,100 +11.4 31,495 5,400 15.4 +2.2 5,285 16.8 5,500 15.7 +6.9 5,146 16.3 3,500 10.0 +30.0 2,692 8.6 -13-
Slide 15: FY2009 forecast versus previous plan
2009 3 ( %) 09/3 ( ) 35,100 -0.3 35,200 5,400 15.4 -10.0 6,000 17.0 5,500 15.7 -11.3 6,200 17.6 3,500 10.0 -5.9 3,720 10.6 -14-
Slide 16: CP RNRAUKSt
-15- CP RNRAUKSt
Slide 17: 20 40 06 34 47 02~05 42 200 D 178 182 120 08/3 09/3
351 08 360 7 16 22 315 11 9 11 8 10 5 10 9 31 07 27 1 21 280 20 40 06 34 47 02~05 42 200 D 178 182 120 08/3 09/3 -16-
Slide 18: 05/3 06/3 07/3 08/3 09/3 -17-
38 40 32 25 24 20 13 0 05/3 06/3 07/3 08/3 09/3 -17-
Slide 19: -18-
-18-
Slide 20: -19- CP MR AAR
-19- CP MR AAR
Slide 21: -20-
-20-
Slide 22: -21-
-21-
Slide 23: -22-
-22-
Slide 24: Product information
GE 07 514 75mg/100mg/ 352 09 100mg 50mg/100mg 224 10% 100mg 442 10 344 10mg/20mg 462 -23-
Slide 25: Contact
TEL 06-6900-9101 FAX 06-6900-0634 -24-